Company Quick10K Filing
Penn Virginia
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-02-27
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-02
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-16
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-07-29
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-03-15
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-05-11
10-K 2014-12-31 Filed 2015-02-25
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-30
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-02-24
10-Q 2013-09-30 Filed 2013-10-30
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-25
10-Q 2012-09-30 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-05-03
10-K 2011-12-31 Filed 2012-02-27
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-02-27
8-K 2019-12-20
8-K 2019-11-07
8-K 2019-11-01
8-K 2019-09-03
8-K 2019-08-07
8-K 2019-08-05
8-K 2019-07-08
8-K 2019-06-03
8-K 2019-05-09
8-K 2019-05-07
8-K 2019-04-15
8-K 2019-03-22
8-K 2019-02-27
8-K 2018-11-08
8-K 2018-10-29
8-K 2018-10-26
8-K 2018-09-10
8-K 2018-08-07
8-K 2018-07-18
8-K 2018-05-08
8-K 2018-05-02
8-K 2018-03-06
8-K 2018-03-01
8-K 2018-03-01
8-K 2018-01-18
8-K 2017-12-30

Penn Virginia Financials

PVA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash327204121483148212518141938231025124644312273914731071171281851311
Accounts Receivable6358726768767271567063641331481941672381891901501057348444032293943487056727266705262
Inventory824148654322222465433222222255464344
PP&E1,5991,6581,7061,7462,4082,4282,5032,5852,6392,4002,4322,5133,0513,0493,1773,3243,1423,3553,7073,7373,8312,8452,7172,7212,7192532592803055295907769081,0161,1221,2231,3161,422
Assets2,0521,9801,9451,9051,8701,8771,9431,9591,9771,8631,8431,8702,4452,4062,5072,5362,5882,7222,2262,1992,1132,0205184674123072923083375626307698889541,0691,0811,1301,212
Accounts Payable3425304137303831728012075113106174122852512182381071072317352017231633
Long-Term Debt5035055075095986136977187796766006331,1421,2031,2811,2651,1301,0751,1101,2371,2871,2151,2451,2221,18854253037257277395444482521525540570
Liabilities1,0179789641,1251,1501,0679489921,5501,6111,7181,7281,5711,6241,5511,5851,5851,4651,4331,4161,42711910694100330408539659708622672668695
Stockholders' Equity1,0351,0039808338277958958788957967898081,0161,099676614528555-915-949-1,015187186215237232222230229246447409462517
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue536964697483808478787883110122117190139205102758411235303763977112127105123119
Cost of Revenue5467
Gross Profit122101116113
R&D
SG&A1613141313139121212101116131517151261211910171015656767
Tax-13223-001-0-0-0-22-0000014042400-1-50000000500-0-011
Net Income50-30-23-26-68-7-28-12-6-33-54-16-25-99-219-10190-418-57-8026-1,472-33-62-3-52855-610-316-395254
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating231129394271457446849537673310182465364729174313982726985
Cash Investing-144-92-100-77-119-94-9424-110-85-538-135-127-64-19055-227-169-9513-28-1410-5-160-126-115-86-89-122
Cash Financing-2-3-210811758-10572364585976-17173-572712143-7830-0-5-21-51117483941230